Study identifies a novel mechanism driving osteosarcoma and provides insights to help predict patient outcomes ...

Daiichi Sankyo buys solid tumour ADC from Glycotope for $132.5m Daiichi Sankyo has finalised the acquisition of intellectual ...

A breakthrough in prostate cancer treatment has seen a drug shrink tumours in advanced disease ...

A breakthrough experimental drug has shown promising results in shrinking advanced prostate cancer tumours, offering new hope ...

The theory is solid, but creating such a bespoke vaccine quickly enough to be of use is a different matter. “Not many years ...

Massachusetts-based IDRx has been developing precision therapeutics for the treatment of gastrointestinal stomal tumours, ...

RECORD numbers of cancers are being diagnosed early when they are more curable, NHS figures show. Nearly six in ten of the 13 ...

Background and objective Gastric cancer (GC) remains a prevalent and preventable disease, yet accurate early diagnostic ...

Under the agreement, GSK will pay $1billion upfront to acquire the Massachussetts-based firm, followed by up to $150million ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

Paediatric brain tumours were the second most common form of childhood cancers, they said. The study said restrictions, which ...

The system is based on novel technology that promises to simplify treatment and delivery and increase the number of patients ...